ARG1 and cancer: Another point that was highlighted by the findings of this study was that the combined model included Arg-1 + HepPar-1, improved the process of cancer diagnosis of HBV-related HCC, especially in fine-needle aspiration samples with too small cell count to evaluate the status of the sample and disease.